Rab 3C inhibitors belong to a distinctive chemical class designed to selectively target and modulate the activity of Rab 3C, a member of the Rab family of small GTPases. The Rab GTPases, critical regulators of intracellular vesicle trafficking and membrane fusion events, play pivotal roles in maintaining cellular homeostasis. Specifically, Rab 3C is implicated in the regulation of exocytosis, the cellular process responsible for the release of various substances, such as neurotransmitters and hormones, from cells. Inhibitors of Rab 3C operate by interfering with the GTPase activity of the protein, a process essential for its proper functioning in cellular transport mechanisms.
Rab 3C inhibitors is characterized by specific motifs and functional groups that enable targeted binding to the active site of Rab 3C, thereby impeding its ability to hydrolyze GTP. This interference disrupts the finely tuned molecular machinery orchestrating vesicle trafficking, leading to downstream effects on cellular processes dependent on exocytosis. The development of Rab 3C inhibitors represents a promising avenue for unraveling the intricate regulatory networks governing intracellular transport, shedding light on the fundamental cellular processes and potentially serving as tools for dissecting the underlying molecular mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
Analog of GTP that can irreversibly activate Rab proteins, preventing the normal cycling off of the pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits ADP-ribosylation factor (ARF), a GTPase that can interact with Rab proteins, altering vesicle trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, which can disrupt trafficking of vesicles, indirectly affecting Rab 3C function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, which can also disrupt vesicle trafficking, indirectly affecting Rab 3C function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which can modulate vesicle trafficking pathways involving Rab proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, affecting vesicle trafficking and signaling pathways related to Rab 3C. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor, which can affect Rho GTPase family members and potentially alter Rab 3C-associated pathways. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits cytohesins, which are ARF GEFs, potentially modulating Rab 3C-related trafficking. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Inhibits the Golgi BFA resistance factor 1 (GBF1), which is involved in trafficking and may affect Rab 3C. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
Small molecule that inhibits multiple Rho GTPases, potentially influencing Rab 3C-related pathways. | ||||||